Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, providing promising progress across a variety of healthcare and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA supplies a safer, much more dependable choice for therapeutic us